Low plasma levels of HDL cholesterol are a risk factor for infection and hospitalization for infectious disease. Recent work suggests that inadequate levels of HDL particles of specific sizes — small and medium — account for this risk. In this Comment, we discuss the mechanistic implications of these observations and the methodologies used to quantify HDL size.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tall, A. R. & Yvan-Charvet, L. Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 15, 104–116 (2015).
Sorci-Thomas, M. G. & Thomas, M. J. Microdomains, inflammation, and atherosclerosis. Circ. Res. 118, 679–691 (2016).
Rosenson, R. S. et al. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin. Chem. 57, 392–410 (2011).
Trinder, M., Walley, K. R., Boyd, J. H. & Brunham, L. R. Causal inference for genetically determined levels of high-density lipoprotein cholesterol and risk of infectious disease. Arterioscler. Thromb. Vasc. Biol. 40, 267–278 (2020).
Harsløf, M., Pedersen, K. M., Afzal, S., Smith, G. D. & Nordestgaard, B. G. Lower levels of small HDL particles associated with increased infectious disease morbidity and mortality: a population-based cohort study of 30 195 individuals. Cardiovasc. Res. https://doi.org/10.1093/cvr/cvac194 (2022).
Ala-Korpela, M., Zhao, S., Järvelin, M. R., Mäkinen, V. P. & Ohukainen, P. Apt interpretation of comprehensive lipoprotein data in large-scale epidemiology: disclosure of fundamental structural and metabolic relationships. Int. J. Epidemiol. 51, 996–1011 (2022).
He, Y. et al. Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles. Circ. Res. 127, 1198–1210 (2020).
Rader, D. J. Molecular regulation of HDL metabolism and function: implications for novel therapies. J. Clin. Invest. 116, 3090–3100 (2006).
Huang, R. et al. Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma. Nat. Struct. Mol. Biol. 18, 416–422 (2011).
Hutchins, P. M. et al. Quantification of HDL particle concentration by calibrated ion mobility analysis. Clin. Chem. 60, 1393–1401 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Heinecke, J.W., Davidson, W.S. Size matters: HDL particle populations and the risk of infection. Nat Rev Cardiol 20, 279–280 (2023). https://doi.org/10.1038/s41569-023-00844-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-023-00844-8